Pages that link to "Q40166521"
Jump to navigation
Jump to search
The following pages link to Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups (Q40166521):
Displaying 50 items.
- Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age (Q24245934) (← links)
- Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci (Q24548662) (← links)
- Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity (Q24812252) (← links)
- Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses (Q26746887) (← links)
- Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance (Q26851961) (← links)
- Pneumococcal Capsules and Their Types: Past, Present, and Future (Q27006887) (← links)
- Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement (Q28069508) (← links)
- Vaccines in the era of genomics: the pneumococcal challenge (Q28290283) (← links)
- The Streptococcus pneumoniae Capsule Is Required for Full Virulence in Pneumococcal Endophthalmitis (Q28386753) (← links)
- Controlling antimicrobial resistance through targeted, vaccine-induced replacement of strains (Q28485487) (← links)
- Immunization of elderly people with polyvalent pneumococcal vaccine (Q30459669) (← links)
- A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice (Q30651292) (← links)
- Combinatorial library cloning of human antibodies to Streptococcus pneumoniae capsular polysaccharides: variable region primary structures and evidence for somatic mutation of Fab fragments specific for capsular serotypes 6B, 14, and 23F (Q30658618) (← links)
- Novel vaccine strategies to T-independent antigens (Q30726038) (← links)
- Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae (Q30864604) (← links)
- Pneumococcal septic arthritis after splenectomy in Felty's syndrome (Q33385276) (← links)
- Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A? (Q33528283) (← links)
- Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae (Q33592253) (← links)
- Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies (Q33592895) (← links)
- Serotype 6B from a pneumococcal polysaccharide vaccine induces cross-functional antibody responses in adults to serotypes 6A, 6C, and 6D. (Q33595352) (← links)
- A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates (Q33603494) (← links)
- Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). (Q33684439) (← links)
- Streptococcus pneumoniae (Q33734675) (← links)
- Molecular characterization of the complete 23F capsular polysaccharide locus of Streptococcus pneumoniae (Q33737741) (← links)
- Glycoprotein conjugate vaccines (Q33743653) (← links)
- Pneumococcal Vaccination Strategies. An Update and Perspective. (Q33772409) (← links)
- Antibiotic resistant Streptococcus pneumoniae (Q33776122) (← links)
- Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides (Q33867137) (← links)
- Ten-year review of invasive pneumococcal diseases in children and adults from Uruguay: clinical spectrum, serotypes, and antimicrobial resistance (Q33875797) (← links)
- Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance (Q33942204) (← links)
- Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). (Q33975380) (← links)
- Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in two Chilean cities (Q33991415) (← links)
- Transplacental transmission of serotype-specific pneumococcal antibodies in a Brazilian population. (Q33997525) (← links)
- Pneumococcal capsular polysaccharide preparations may contain non-C-polysaccharide contaminants that are immunogenic (Q33997738) (← links)
- Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine (Q33998938) (← links)
- Repertoire of human antibodies against the polysaccharide capsule of Streptococcus pneumoniae serotype 6B. (Q34000570) (← links)
- Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice (Q34003957) (← links)
- Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B (Q34005631) (← links)
- Molecular characterization of Streptococcus pneumoniae type 4, 6B, 8, and 18C capsular polysaccharide gene clusters (Q34006164) (← links)
- Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995. (Q34027404) (← links)
- Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable heavy chain repertoire (Q34111761) (← links)
- Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration (Q34113328) (← links)
- Rethinking recommendations for use of pneumococcal vaccines in adults (Q34326459) (← links)
- Validation of a multiplex pneumococcal serotyping assay with clinical samples. (Q34345170) (← links)
- Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate. (Q34529116) (← links)
- Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae (Q34549615) (← links)
- Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis (Q34621983) (← links)
- Development and evaluation of pneumococcal conjugate vaccines: clinical trials and control tests (Q34632848) (← links)
- Impact of the Conjugation Method on the Immunogenicity of Streptococcus pneumoniae Serotype 19F Polysaccharide in Conjugate Vaccines (Q34738780) (← links)
- Penicillin-resistant Streptococcus pneumoniae septic shock and meningitis complicating chronic graft versus host disease: a case report and review of the literature (Q34754715) (← links)